Gilead Sciences Stock (BIT:GILD)

ITALY |MI |EUR

Price
58.40
Change
-1.68%
Today's Range
58.40 - 59.82
52-Week Range
50.87 - 63.67
Market Cap
78.14B
Volume
400.00

About Gilead Sciences (BIT:GILD)

(BIT:GILD) Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Show more

GILD Stock Price

Statistics Highlights (BIT:GILD)

Shares Outstanding 1.25B Beta 0.39
Public Float 1.25B P/E Ratio 17.28
% Short of Float - Dividend (Yield) 2.86 (0.04%)
Held by Insiders 0.06% Ex-Dividend Date Jun 14, 2022
Held by Institutions 82.11% IPO Date -

GILD Financial Summary

|
Revenue
EBITDA
Net Income
Total Assets
Total Cash
Total Debt
Revenue
EBITDA
Net Income
Total Assets
Total Cash
Total Debt

(BIT:GILD) Stock Price FAQs

What is today's stock price of Gilead Sciences (BIT:GILD)?

  • The current stock price of Gilead Sciences (BIT:GILD) is €58.40.
  • Today GILD stock price opened at €59.82 after previous close of €59.40.
  • During the day, Gilead Sciences stock quote has varied from a low of €58.40 to a high of €59.82.

What is Gilead Sciences's 52-week change?

  • GILD 52-week high stock quote is €63.67, which is 9.00% above the current share price.
  • The Gilead Sciences (BIT:GILD) 52-week low stock price is €50.87, which is 12.90% below the current share price.
  • Gilead Sciences share price volatility (52-week beta) is 0.39.

Gilead Sciences (BIT:GILD) FAQ

How Much is Gilead sciences Worth?

Gilead sciences's worth today based on market capitalisation is €78.14B

How much dividend does Gilead sciences Pay?

The current annualized dividend payout for GILD stock is €2.77, the dividend yield is 4.48% and the payout ratio is 95.28%.
View More Details on Gilead sciences's "Dividend" Section

When is the next earnings date for Gilead sciences (BIT:GILD)?

Gilead sciences is expected to report earnings on October 26 ,2022.
View More Details on Gilead sciences's 'Earnings' Section

What is Gilead sciences’s Price to Earning (PE) ratio?

Gilead sciences has a Price to Earning (P/E) ratio of 17.28. GILD stock also has a Price to Sales (P/S) ratio of 2.84, a Price to Book of 3.97 and Price/Earnings to Growth (PEG) of 0.54.

What is the Gilead sciences's ticker?

Gilead sciences trades on the Milan stock market in Italy under the ticker symbol "GILD". Gilead sciences’s stock symbol can also be displayed as "BIT:GILD".

Who are the owners of Gilead sciences?

Gilead sciences (BIT:GILD) is owned by 82.11% institutional shareholders and by 0.06% insiders. The rest is owned by the public.
Explore More Details on Gilead sciences's “Ownership” Section

Who are the key executives of Gilead sciences (GILD)?

Gilead sciences's key executive team includes the following managers:

  • Mr. Daniel P. O'Day, Chairman & CEO (1964)
  • Mr. Andrew D. Dickinson, Exec. VP & CFO (1970)
  • Mr. Brett A. Pletcher, Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec. (1969)
  • Ms. Johanna Mercier, Chief Commercial Officer (1970)
  • Dr. Merdad V. Parsey M.D., Ph.D., Chief Medical Officer (1963)
  • Ms. Diane E. Wilfong, Sr. VP, Corp. Controller & Chief Accounting Officer (1962)
  • Ms. Jacquie Ross C.F.A., VP of Investor Relations (NA)
  • Ms. Jyoti K. Mehra, Exec. VP of HR (NA)
  • Dr. Taiyin Yang Ph.D., Exec. VP of Pharmaceutical Devel. & Manufacturing (1954)
  • Dr. Michael Quigley Ph.D., Sr. VP of Research Biology (NA)

What is Gilead sciences’s Sector & Industry Classification?

Gilead sciences (BIT:GILD) is classified under the "Healthcare" sector and under the "Drug Manufacturers-General" industry.

How many employees work for Gilead sciences?

Currently the number of employees working for Gilead sciences is 14,400.

Where are Gilead sciences's Headquarters?

Gilead sciences (BIT:GILD) is headquartered in CA, United States.

What are Gilead sciences's Address and Phone Number?

Gilead sciences’s mailing address is 333 Lakeside Drive, Foster City, CA, United States, 94404.
The company’s phone number is 650 574 3000.

What is the official website for Gilead sciences?

Gilead sciences’s official website is https://www.gilead.com